Belvedere Trading’s Biomea Fusion BMEA Stock Holding History

Belvedere Trading’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,457	Closed	-$734K	–	872
2023 Q1	$727K	Buy	+23,457	New	+$292K	﹤0.01%	103

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Belvedere Trading's BMEA Position: Q2 2023 in Review

Belvedere Trading sold out of Biomea Fusion (BMEA) in Q2 2023, closing a stake of 23,457 shares — an estimated $734K sold.

Belvedere Trading first reported a position in BMEA in Q1 2023 and held it in 1 quarter. The position peaked at $727K in Q1 2023. 90 funds tracked by Wall St. Rank hold BMEA as of Q2 2023.

Belvedere Trading reported no remaining Biomea Fusion position as of Q2 2023 after selling out during the quarter.
Belvedere Trading sold 23,457 Biomea Fusion shares in Q2 2023, an estimated $734K.
Belvedere Trading first reported a position in Biomea Fusion in Q1 2023 and held it in 1 quarter.
Belvedere Trading's Biomea Fusion position peaked at $727K in Q1 2023.
90 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2023.

Based on Belvedere Trading's 13F filing for Q2 2023, filed 8 Aug 2023.